Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 145,313 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorder Clear all

Conditions: Acute Myeloid Leukemia
Interventions: Venetoclax, Gemtuzumab, Ziftomenib; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 3 Years to 21 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Open Angle Glaucoma, Primary Open Angle Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma in Both Eyes
Interventions: Glaucoma and Cataract Surgery; Procedure
Lead sponsor: Wills Eye; Other
Eligibility: 40 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: IgA Nephropathy
Interventions: BHV-1400; Drug
Lead sponsor: Biohaven Therapeutics Ltd.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 14
States / cities: Farmington, Connecticut • Miami Lakes, Florida • Orlando, Florida + 9 more

Conditions: Refractory Epilepsy, Arrhythmia, Sudden Death
Interventions: Medtronic REVEAL; Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 16 Years to 49 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: genistein, gemcitabine, Tumor biopsy; Dietary Supplement · Drug · Procedure
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Muscular Dystrophy
Interventions: Tadalafil 20 MG, beetroot juice extract; Drug · Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Brain Tumor
Interventions: Demeclocycline; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alzheimers Disease
Interventions: No Intervention; Other
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 80,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 68
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 60 more

Conditions: Carotid Stenosis
Interventions: Gadobutrol (Gadovist, BAY86-4875); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 479 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 15
States / cities: Tucson, Arizona • Jacksonville, Florida • Savannah, Georgia + 12 more

Conditions: Breast Cancer
Interventions: High Resolution Microendoscope; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 213 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Autism Spectrum Disorder
Interventions: Reciprocal Imitation Training; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 16 Months to 33 Months
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 4
States / cities: Chicago, Illinois • Boston, Massachusetts • East Lansing, Michigan + 1 more

Conditions: Thrombosis
Interventions: Heparin sulfate infusion at 10 units/kg/hour, Placebo infusion; Drug
Lead sponsor: Stanford University; Other
Eligibility: 1 Day to 1 Year
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Stanford, California

Conditions: Tobacco Use Disorder
Interventions: nicotine transdermal system; Drug
Lead sponsor: New York University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 585 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 13
States / cities: Los Angeles, California • Tarzana, California • Miami, Florida + 8 more

Conditions: Constrictive Bronchiolitis
Interventions: X-ray velocimetry analyzed by 4Dx XV Ventilation Analysis; Diagnostic Test
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Substance Use (Drugs, Alcohol)
Interventions: Integrated Intervention for Dual Problems and Early Action; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Somerville, Massachusetts

Conditions: Hypercholesterolemia, LDL Cholesterol
Interventions: LGT209 50 mg, LGT209 300 mg, Placebo, Statins (atorvastatin or simvastatin); Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Fort Myers, Florida • Miramar, Florida

Conditions: Healthy
Interventions: INO-3401 + EP; Biological
Lead sponsor: Inovio Pharmaceuticals; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Overland Park, Kansas • Rockville, Maryland

Conditions: Blepharospasm, Focal Dystonia
Interventions: repetitive transcranial magnetic stimulation (rTMS); Procedure
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cervical Degenerative Disc Disorder
Interventions: Simplify Disc, ACDF; Device · Other
Lead sponsor: NuVasive; Industry
Eligibility: Not listed
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 15
States / cities: Orange, California • San Diego, California • Santa Monica, California + 12 more

Conditions: End Stage Renal Disease
Interventions: Hemoaccess Valve System; Device
Lead sponsor: Diaxamed LLC; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Breast Cancer
Interventions: Breast Cancer Screening, Survey/Interview, Focus Group; Diagnostic Test · Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 30 Years to 75 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Waldenstrom's Macroglobulinemia
Interventions: Bortezomib, Dexamethasone, Rituximab; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Pneumococcal Pneumonia
Interventions: Pharmacist Vaccine Education; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 19 Years to 64 Years
Enrollment: 431 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Midlothian, Virginia • Richmond, Virginia

Conditions: Colon Cancer
Interventions: Not listed
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 5
States / cities: Los Angeles, California • Evanston, Illinois • Indianapolis, Indiana + 1 more

Search by objective public record fields.

A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia

IOP and Medication Reduction in MIGS Procedures

Study of BHV-1400 in IgA Nephropathy

Cardiac Rhythm Abnormalities in Patients With Refractory Epilepsy at High Risk for Sudden Death

Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer

The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy

Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Gadobutrol Enhanced MRA of the Supra-aortic Vessels

Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy

Improving the Part C Early Intervention Service Delivery System for Children With ASD

Heparin and the Reduction of Thrombosis (HART) Trial

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

4DX for the Diagnosis of Constrictive Bronchiolitis

International Latino Research Partnership

Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001

Brain Stimulation to Treat Blepharospasm or Meige Syndrome

Post-Approval Study Protocol for the Simplify Cervical Artificial Disc

A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement

Individuals on Hormone Therapy Breast Cancer Screening Pilot

Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia

Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain

Novel Biophotonics Methodology for Colon Cancer Screening